Showing results (221-230 of 290) with videos related to

Sort By:
Pageof 29
BMC Nephrology|February 15, 2018
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes ModelPhil McEwan, Hayley Bennett Wilton, Albert C M Ong, et al.
Circulation Research|July 11, 2009
Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathySebastian Carballo, Paul Robinson, Robyn Otway, et al.
Therapeutic Innovation & Regulatory Science|February 25, 2017
Culture and Process Change as a Priority for Patient Engagement in Medicines DevelopmentMarc Boutin, Lode Dewulf, Anton Hoos, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 14, 2007
Subject classification obtained by cluster analysis and principal component analysis applied to flow cytometric dataEnrico Lugli, Marcello Pinti, Milena Nasi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 29, 2014
A systematic assessment of mitochondrial function identified novel signatures for drug-induced mitochondrial disruption in cellsNianyu Li, Elisa Oquendo, Roderick A Capaldi, et al.
Hepatology (Baltimore, Md.)|June 15, 2021
The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary CholangitisBen Barron-Millar, Laura Ogle, George Mells, et al.
European Eating Disorders Review : the Journal of the Eating Disorders Association|August 3, 2011
Service providers' perceptions of the strengths and prospective improvements in UK eating disorder services: findings from a Royal College surveyAntonia Koskina, Jamie Arkell, Gerard Butcher, et al.
Frontiers in Microbiology|March 8, 2021
Elastic Light Scatter Pattern Analysis for the Expedited Detection of Yersinia Species in Pork Mince: Proof of ConceptStephen L W On, Yuwei Zhang, Andrew Gehring, et al.
Equine Veterinary Journal|November 28, 2020
Tiludronic acid can be detected in blood and urine samples from Thoroughbred racehorses over 3 years after last administrationChris M Riggs, Sarah L Thompson, Yat-Ming So, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept studyXavier Bertagna, Rosario Pivonello, Maria Fleseriu, et al.
Pageof 29